REVENUES

3 Months Ended

Mar. 31, 2022

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three Months Ended March 31,
(U.S. dollars in thousands)	2022		2021
Pfizer	$	3,356	$	4,511
Brazil	$	5,454	$	—
Chiesi	$	218	$	—
Total revenues from selling goods	$	9,028	$	4,511
Revenues from license and R&D services	$	7,057	$	6,809